Argos Therapeutics Inc fka ARGSQ

[l2 hunter]

ARGS NEWS >>>> Item 1.01 Entry Into a Material Definitive Agreement

On June 15, 2017, Argos Therapeutics, Inc. (the “Company”) entered into a note purchase agreement (the “Note Purchase Agreement”) with Pharmstandard International S.A. (“Pharmstandard”), pursuant to which the Company agreed to issue and sell to Pharmstandard a convertible secured promissory note in the original principal amount of $6,000,000 (the “Note”) in a private placement (the “Financing”).